The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease

Background: The study aims to assess the feasibility of using a combined approach of liver function indices and FibroScan measurements as a predictive tool for the early detection of anti-tuberculosis drug-induced liver injury (DILI) in patients with existing liver disease. Methods: A retrospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaoqiang Wu, Qiaohua Yang, Huai Li, Yongzhong Li
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2025-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501017S.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832096632114511872
author Shaoqiang Wu
Qiaohua Yang
Huai Li
Yongzhong Li
author_facet Shaoqiang Wu
Qiaohua Yang
Huai Li
Yongzhong Li
author_sort Shaoqiang Wu
collection DOAJ
description Background: The study aims to assess the feasibility of using a combined approach of liver function indices and FibroScan measurements as a predictive tool for the early detection of anti-tuberculosis drug-induced liver injury (DILI) in patients with existing liver disease. Methods: A retrospective cohort study was conducted, including adult tuberculosis patients with documented liver disease. Liver function was assessed using standard biochemical parameters, and FibroScan examinations were performed to determine liver stiffness measurement (LSM). Patients were monitored for clinical and biochemical signs of DILI throughout treatment. Logistic regression models and Receiver Operating Characteristic (ROC) curves were used for data analysis. Statistical significance was set at P<0.05. Results: Patients who developed DILI showed significantly higher levels of ALT, AST, total bilirubin, GGT, and LSM, with strong positive correlations between these markers and DILI occurrence. Logistic regression analysis revealed elevated ALT, AST, TBIL, and GGT were strongly associated with an increased likelihood of DILI. The area under the ROC curves indicated excellent predictive accuracy of these parameters. A nomogram for predicting DILI based on the combined biomarkers was established. Conclusions: The study demonstrates the feasibility of combining liver function indices and FibroScan measurements to predict anti-tuberculosis DILI. The results highlight the importance of baseline liver health assessment and offer promising implications for clinical practice, aiding in individualized risk estimation and therapeutic decision-making for patients with liver disease initiating anti-tuberculosis therapy. Further validation in larger cohorts is warranted to strengthen the predictive model.
format Article
id doaj-art-f2dc1d4fa2054edaa29c6efcf292c6c6
institution Kabale University
issn 1452-8258
1452-8266
language English
publishDate 2025-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj-art-f2dc1d4fa2054edaa29c6efcf292c6c62025-02-05T13:11:23ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662025-01-01441172310.5937/jomb0-508781452-82582501017SThe feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver diseaseShaoqiang Wu0Qiaohua Yang1Huai Li2Yongzhong Li3Hunan University of Medicine General Hospital, Infectious Disease Center, Department of Hepatology, Huaihua, ChinaHunan University of Medicine General Hospital, Infectious Disease Center, Department of Hepatology, Huaihua, ChinaHunan University of Medicine General Hospital, Infectious Disease Center, Department of Hepatology, Huaihua, ChinaHunan University of Medicine General Hospital, Infectious Disease Center, Department of Hepatology, Huaihua, ChinaBackground: The study aims to assess the feasibility of using a combined approach of liver function indices and FibroScan measurements as a predictive tool for the early detection of anti-tuberculosis drug-induced liver injury (DILI) in patients with existing liver disease. Methods: A retrospective cohort study was conducted, including adult tuberculosis patients with documented liver disease. Liver function was assessed using standard biochemical parameters, and FibroScan examinations were performed to determine liver stiffness measurement (LSM). Patients were monitored for clinical and biochemical signs of DILI throughout treatment. Logistic regression models and Receiver Operating Characteristic (ROC) curves were used for data analysis. Statistical significance was set at P<0.05. Results: Patients who developed DILI showed significantly higher levels of ALT, AST, total bilirubin, GGT, and LSM, with strong positive correlations between these markers and DILI occurrence. Logistic regression analysis revealed elevated ALT, AST, TBIL, and GGT were strongly associated with an increased likelihood of DILI. The area under the ROC curves indicated excellent predictive accuracy of these parameters. A nomogram for predicting DILI based on the combined biomarkers was established. Conclusions: The study demonstrates the feasibility of combining liver function indices and FibroScan measurements to predict anti-tuberculosis DILI. The results highlight the importance of baseline liver health assessment and offer promising implications for clinical practice, aiding in individualized risk estimation and therapeutic decision-making for patients with liver disease initiating anti-tuberculosis therapy. Further validation in larger cohorts is warranted to strengthen the predictive model.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501017S.pdfliver function indicesfibroscananti-tuberculosis drug-induced liver injuryliver diseasenomogram
spellingShingle Shaoqiang Wu
Qiaohua Yang
Huai Li
Yongzhong Li
The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
Journal of Medical Biochemistry
liver function indices
fibroscan
anti-tuberculosis drug-induced liver injury
liver disease
nomogram
title The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
title_full The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
title_fullStr The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
title_full_unstemmed The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
title_short The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
title_sort feasibility of using liver function indices and fibroscan in combination to predict the occurrence of anti tuberculosis drug induced liver injury in patients with liver disease
topic liver function indices
fibroscan
anti-tuberculosis drug-induced liver injury
liver disease
nomogram
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501017S.pdf
work_keys_str_mv AT shaoqiangwu thefeasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT qiaohuayang thefeasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT huaili thefeasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT yongzhongli thefeasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT shaoqiangwu feasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT qiaohuayang feasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT huaili feasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease
AT yongzhongli feasibilityofusingliverfunctionindicesandfibroscanincombinationtopredicttheoccurrenceofantituberculosisdruginducedliverinjuryinpatientswithliverdisease